Wait...
Search Global Export Import Trade Data
Recent Searches: No Recent Searches

Date: 01-02-2025
Notification No: Notification No. 09/2025-Customs
Issuing Authority: Indian Customs  
Type: Tariff
File No: [F. No. 334/03/2025-TRU]
Subject: Seeks to further amend notification No. 16/2017-Customs, dated the 20 th April, 2017 so to exempt certain drugs for supply under Patient Assistance Programme run by specified pharmaceutical companies.
Untitled 1

[TO BE PUBLISHED IN THE GAZETTE OF INDIA, EXTRAORDINARY, PART II, SECTION 3,
SUB-SECTION (i)]
GOVERNMENT OF INDIA
MINISTRY OF FINANCE
(Department of Revenue)
Notification No. 09/2025-Customs
New Delhi, the 1st February, 2025

 G.S.R….(E).- In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act,
1962 (52 of 1962), the Central Government, on being satisfied that it is necessary in the public interest so to do,
hereby makes the following further amendments in the notification of the Government of India in the Ministry of
Finance (Department of Revenue) No. 16/2017-Customs, dated the 20th April, 2017, published in the Gazette of
India, Extraordinary, Part II, Section 3, Sub-section (i), vide number G.S.R. 394(E), dated the 20th April, 2017,
namely :-

In the said notification, in the TABLE, after serial number 52 and the entries relating thereto, the following
serial numbers and the entries shall be inserted, namely :-

(1) (2) (3) (4)
“53. Pembrolizumab Key- PAP 1.0 MSD Pharmaceuticals
54. Pembrolizumab KIRAN MSD KIRAN MSD Pharmaceuticals
55 Lorlatinib LorbriquaCare LorbriquaCare Pfizer Products India Private Ltd.
56 Dacomitinib  DacoCare Pfizer Products India Private Ltd.
57 Inotuzumab Ozogamicin HemaCare Pfizer Products India Private Ltd
58 Ribociclib UMAANG Novartis Healthcare Pvt. Ltd.
59 Dabrafenib UMAANG Novartis Healthcare Pvt. Ltd.
60 Selumetinib AstraZeneca Pharma AstraZeneca Pharma India Limited
61 Benralizumab AstraZeneca Pharma PAP AstraZeneca Pharma India Limited
62 Fulvestrant AstraZeneca Pharma AstraZeneca Pharma India Limited
63 Acalabrutinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited
64 Olaparib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited
65 Amivantamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
66 Teclistamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
67 Ustekinumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
68 Daratumumab
And hyaluronidase-fihj
Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
69 Ibrutinib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
70 Bortezomib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
71 Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd.
72 Cetuximab Rainbow PAP Merck Specialties Pvt. Ltd.
73 Avelumab My Bavencio Assist Program Merck Specialties Pvt. Ltd.
74 Tepotinib My Tepmetko Patient Access
Program
Merck Specialties Pvt. Ltd.
75 Brentuximab Vedotin Takeda PAP Biopharmaceuticals India Pvt.
Limited
76 Vedolizumab Takeda PAP Takeda Biopharmaceuticals India Pvt.
Limited
77 Velaglucerase Takeda PAP Takeda Biopharmaceuticals India Pvt.
Limited
78 Agalsidase Alpha Takeda PAP Biopharmaceuticals India Pvt.
Limited
79 Idursulphase Takeda PAP Takeda Biopharmaceuticals India Pvt.
Limited
80 Mepolizumab GSK Pharmaceuticals Limited GSK Pharmaceuticals Limited
81 Alectinib The Blue Tree Roche Products India Private Ltd.
82 Risdiplam Powder The Blue Tree Roche Products India Private Ltd.
83 Emicizumab The Blue Tree Roche Products India Private Ltd.
84 Atezolizumab The Blue Tree Products India Private Ltd.
85 Pertuzumab +
trastuzumab
The Blue Tree Products India Private Ltd.
86 Ocrelizumab The Blue Tree Roche Products India Private Ltd.
87 Polatuzumab vedotin The Blue Tree Roche Products India Private Ltd.
88 Faricimab The Blue Tree Roche Products India Private Ltd
89 Luspatercept Bristol-Myers Patient Assistance
Program
Bristol-Myers Squibb India Pvt. Ltd. ”

  
  2. This notification shall come into force on the 2nd day of February, 2025.

[F. No. 334/03/2025-TRU]
(Amreeta Titus)
Deputy Secretary to the Government of India

Note: The principal notification No. 16/2017-Customs, dated the 20th April, 2017 was published in the Gazette of
India, Extraordinary, Part II, Section 3, Sub-Section (i), vide number G.S.R. 394(E), dated the 30th June, 2017.  

       

Get Sample Now

Which service(s) are you interested in?
 Export Data
 Import Data
 Both
 Buyers
 Suppliers
 Both
OR
 Exim Help
+


What is New?

Date: 27-03-2026
Notification No. 05/2026-Central Excise
Corrigendum to Notification No. 06/2026-Central Excise dated 26.03.2026

Date: 27-03-2026
Corrigendum
Corrigendum to Notification No. 11/2026-Central Excise dated 26.03.2026

Date: 26-03-2026
Notification No. 11/2026-Central Excise
Seeks to prescribe rates of Road and Infrastructure Cess for petrol and diesel, when cleared for exports

Date: 26-03-2026
Notification No. 12/2026-Central Excise
Seeks to amend notification No.4/2019-Central Excise to exclude the provisions of the notification on petrol and diesel when cleared for exports.

Date: 26-03-2026
Notification No. 13/2026- Central Excise
Seeks to rescinderst while notification

Date: 26-03-2026
Notification No. 06/2026-Central Excise
Seeks to levy Special Additional Excise Duty on export of petrol and diesel.

Date: 26-03-2026
Notification No. 07/2026-Central Excise
Seeks to amend the Eighth Schedule to Finance Act, 2002 to insert Aviation Turbine Fuel in the Schedule and prescribe Special Additional Excise Duty on it

Date: 26-03-2026
Notification No. 8/2026-Central Excise
Seeks to prescribe an effective rate of Special Additional Excise Duty on Aviation Turbine Fuel when cleared for exports

Date: 26-03-2026
Notification No. 9/2026-Central Excise
Seeks to exempt Aviation Turbine Fuel from whole of Special Additional Excise Duty except when cleared for exports

Date: 26-03-2026
Notification No. 10/2026-Central Excise
Seeks to exempt applicable basic excise duty and Agriculture Infrastructure and Development Cess on petrol and diesel and basic excise duty on Aviation Turbine Fuel, when cleared for exports



Exim Guru Copyright © 1999-2026 Exim Guru. All Rights Reserved.
The information presented on the site is believed to be accurate. However, InfodriveIndia takes no legal responsibilities for the validity of the information.
Please read our Terms of Use and Privacy Policy before you use this Export Import Data Directory.

EximGuru.com

C/o InfodriveIndia Pvt Ltd
F-19, Pocket F, Okhla Phase-I
Okhla Industrial Area
New Delhi - 110020, India
Phone : 011 - 40703001